Status:
COMPLETED
Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)
Lead Sponsor:
Pfizer
Conditions:
Staphylococcal Infections
Eligibility:
All Genders
Brief Summary
Drug use investigation of Zyvox for patients with Methicillin-resistant Staphylococcus aureus (MRSA) infection disease. The objective of this surveillance is to collect information about 1) adverse d...
Detailed Description
All the patients whom an investigator prescribes the first Linezolid should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into th...
Eligibility Criteria
Inclusion
- Patients need to be administered Linezolid in order to be enrolled in the surveillance.
Exclusion
- Patients not administered Linezolid.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
1004 Patients enrolled
Trial Details
Trial ID
NCT00666276
Start Date
February 1 2007
End Date
April 1 2011
Last Update
July 2 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.